From: Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study
Anticoagulants
HR
95% CI
log-rank P
DOACs vs warfarin
4.045
0.517–37.668
0.143
heparin vs warfarin
1.826
0.114–29.273
0.666
DOACs vs heparin
2.150
0.275–16.835
0.448